Article Information
History
- December 17, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Faculty of Medicine and Health Sciences, Department of Biomedical and Clinical Sciences, Division of Sensory Organs and Communication, Linköping University
- 2Region Östergötland Anaesthetics, Operations and Specialty Surgery Center, Department of Otorhinolaryngology
- 3Regional Cancer Center Western Sweden, Sahlgrenska University Hospital, Gothenburg, Sweden
- 4Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
- 5Department of Otorhinolaryngology – Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- 6Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska Hospital, Stockholm, Sweden
- 7Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- ↵*Corresponding author
Charbél Talani, Universitetssjukhuset I Linköping, 58185 Linköping, Sweden +46101032522 Charbel.talani{at}regionostergotland.se
Posted December 17, 2023.
Six-month mortality has decreased for patients with curative treatment for head and neck cancer in Sweden
